Suppr超能文献

使用双血液吸附装置成功治疗严重内毒素性脓毒症休克的体外血液净化疗法:一例报告

Successful Extracorporeal Blood Purification Therapy using Double Haemoadsorption Device in Severe Endotoxin Septic Shock: A Case Report.

作者信息

Ferraro Stefano, Bianzina Stefania, Mocka Sonila, Cappadona Francesca, Traverso Giovanni Battista, Massarino Fabio, Esposito Pasquale

机构信息

Unità di Nefrologia, San Paolo Hospital, Savona, Italy.

Neonatal and Pediatric Intensive Care Unit, Emergency Department, IRCCS Istituto Giannina Gaslini, Genova, Italy.

出版信息

J Crit Care Med (Targu Mures). 2022 Nov 12;8(4):292-295. doi: 10.2478/jccm-2022-0028. eCollection 2022 Oct.

Abstract

INTRODUCTION

In patients admitted to the Intensive Care Unit (ICU), sepsis can lead to acute kidney injury (AKI), which may require the initiation of continuous renal replacement therapy (CRRT) in 15-20% of cases. There is no consensus about the best extracorporeal treatment to choose in septic patients with AKI.

CASE PRESENTATION

We describe the case of a 70-year-old woman admitted to the ICU with a severe endotoxin septic shock due to Neisseria meningitidis serogroup C. Despite prompt medical intervention, including fluid resuscitation, high dose vasopressor, inotrope support, and broad-spectrum antimicrobial treatment, in a few hours patient's haemodynamic worsened and she developed multi-organ failure, including severe AKI, requiring CRRT. So, continuous veno-venous haemodiafiltration was started, using an oXiris® haemodiafilter set, in series with an adsorber device (CytoSorb®). After 48 hours of this combined extracorporeal treatment, haemodynamic parameters improved, allowing a significant reduction of the vasoactive therapy, with a concomitant decrease in endotoxin and inflammatory markers serum levels. In the following days patient's conditions still improved and renal function recovered.

CONCLUSIONS

Timely extracorporeal blood purification therapy, using a double haemoadsorption device, may be effective in the management of severe septic shock.

摘要

引言

在入住重症监护病房(ICU)的患者中,脓毒症可导致急性肾损伤(AKI),在15%至20%的病例中可能需要启动持续肾脏替代治疗(CRRT)。对于患有AKI的脓毒症患者选择最佳的体外治疗方法尚无共识。

病例介绍

我们描述了一名70岁女性患者的病例,该患者因C群脑膜炎奈瑟菌导致严重内毒素性脓毒症休克入住ICU。尽管进行了及时的医疗干预,包括液体复苏、高剂量血管升压药、强心药支持和广谱抗菌治疗,但在数小时内患者的血流动力学恶化,并出现多器官功能衰竭,包括严重的AKI,需要进行CRRT。因此,使用oXiris®血液透析滤过器套装并与吸附装置(CytoSorb®)串联,开始进行持续静脉-静脉血液透析滤过。经过48小时的这种联合体外治疗后,血流动力学参数得到改善,血管活性治疗得以显著减少,同时内毒素和炎症标志物血清水平降低。在接下来的几天里,患者的病情仍在改善,肾功能恢复。

结论

使用双重血液吸附装置进行及时的体外血液净化治疗可能对严重脓毒症休克的治疗有效。

相似文献

本文引用的文献

5
The Surviving Sepsis Campaign Bundle: 2018 update.拯救脓毒症运动集束化治疗方案:2018年更新版
Intensive Care Med. 2018 Jun;44(6):925-928. doi: 10.1007/s00134-018-5085-0. Epub 2018 Apr 19.
7
Host innate immune responses to sepsis.宿主对脓毒症的固有免疫反应。
Virulence. 2014 Jan 1;5(1):36-44. doi: 10.4161/viru.25436. Epub 2013 Jun 17.
8
Pathogenesis of meningococcemia.脑膜炎球菌血症的发病机制。
Cold Spring Harb Perspect Med. 2013 Jun 1;3(6):a012393. doi: 10.1101/cshperspect.a012393.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验